What is the recommended daily dose of Seladelpar?

Seladelpar is a selective peroxisome proliferator-activated receptor delta (PPARdelta) agonist, mainly used to treat hepatobiliary diseases such as primary biliary cholangitis (PBC). As a new oral drug that targets bile metabolism and liver inflammatory response, the recommended daily dosage of Siladepa has been verified by multiple clinical studies to ensure that it can reduce the incidence of adverse reactions while exerting its efficacy.

Based on current clinical trials and published data, the standard recommended dose of Siladepa is 10 mg once daily. This dose has shown good efficacy and safety in multiple Phase III clinical trials, and can significantly reduce alkaline phosphatase (ALP) levels in PBC patients while improving liver function indicators. Daily10mgIt is easy to take and facilitates long-term maintenance treatment, which helps patients adhere to medication and achieve sustained and stable disease control.

However, in certain groups, such as patients with abnormal kidney or liver function, doctors may adjust the dose or strengthen monitoring based on individual circumstances. In clinical trials, lower doses (e.g., 5 mg) have also been used in early assessments to observe tolerability and initial response. For those who do not respond well to conventional doses or experience discomfort, it is also necessary to consider adjusting the medication strategy under the guidance of a doctor.

In general, the recommended daily dose of Siladepa is 10mg, which is mainly taken once a day and has high compliance and treatment stability. Patients should follow the doctor's guidance during medication, regularly monitor liver function and bile biochemical indicators, and pay attention to observe whether reactions such as liver discomfort, fatigue, and skin itching occur. Any abnormalities should be reported to the doctor in time so that the treatment plan can be scientifically adjusted to maximize the efficacy and minimize side effects.

Reference materials:https://www.drugs.com